CPhI North America is a marketplace designed to bring key business leaders together in order to foster dynamic business relationships. Our inaugural show will be the epicenter for innovation, emerging trends, insights, and education in North America,...
in-PHARMA JAPAN is Asia's Leading exhibition specialised in Pharmaceutical Ingredients from APIs, intermediates, excipient, to formulation. Along with INTERPHEX JAPAN, you can meet all key players in the Japanese huge pharmaceutical market.
NTERPHEX JAPAN is the world's leading trade show specialised in Pharmaceutical R&D and Manufacturing. Covering the whole process of pharmaceutical production, it promises you to find business solutions among over 1,000 exhibitors worldwide.
Making drugs deliver: The formulations and technologies that will turn promising candidates into blockbuster products. Even the most promising drug candidate only becomes a successful product if it can be delivered in an effective manner. The solid dosage...
CPhI North America brings together the entire pharma eco-system, from early discovery to commercialization, under one roof, offering you access to the right partners at any stage of development. To register, go to cphinorthamerica.com/register!
DCAT Sharp Sourcing 2017 is a conference and networking event that provides peer and customer insight on the best practices and practical ways for optimizing pharmaceutical manufacturing and supply networks. The event is designed for senior to mid-level...
The concept of a dosage form has been around for a long time. 2,400 years ago, Sumerian doctors in Nippur, an ancient city located in modern day Iraq, detailed how to make medical treatments in recipes written on clay tablets.In the millennia since, dosage...
Drug counterfeiting: a pharmaceutical industry problemCounterfeiters rely on two things: poorly secured pharmaceutical supply chains; and the fact people want to pay less for less for drugs.Most fake erectile dysfunction drugs seized in Europe contain...
Drug counterfeiting: a pharmaceutical industry problemCounterfeiters rely on two things: poorly secured pharmaceutical supply chains; and the fact people want to pay less for less for drugs.
Consumption patterns in the 4 key global markets (Europe, US, India, China)Key market drivers and restraints and their impact on consumptionCompetitive landscape in the Specialty excipients market globally and local specificitiesMarket outlook: where...
This event will examine the drug excipients market, from the historical events that have defined the sector to the debates going on at the moment to predictions about the demands that will drive it in the future.How did the DEG tragedies of the last century...
This event will examine the drug excipients market, from the historical events that have defined the sector to the debates going on at the moment to predictions about the demands that will drive it in the future.How did the DEG tragedies of the last century...
It is a well-established principal that even the most promising API, monoclonal antibody or therapeutic peptide can only be turned into an effective and marketable drug if formulated in such a way that it reaches the blood stream and is bioavailable.But,...
How healthy is demand for bioavailability enhancement services? Is the growth of the generics sector driving the market or do innovative pharma firms determine the type of solubility solutions that are available.When biopharmaceutical are injected they...
